Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
After this loading phase, most patients transition to monthly maintenance sessions
Select any of the image buttons to change the main image
Highly recommend them
Sources Wilding JPH et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," NEJM 2021 (STEP 1 trial, 14.9% weight loss at 68 weeks) Jastreboff AM et al., "Tirzepatide Once Weekly for the Treatment of Obesity," NEJM 2022 (SURMOUNT-1 trial, up to 22.5% weight loss at 72 weeks) FDA Warning Letter Database and April 15, 2026 Federal Register action on Category 2 peptide bulk substances, FDA.gov DOJ press releases, late 2025, on criminal guilty pleas in grey-market peptide distribution cases PubMed systematic reviews, 2024-2025, on BPC-157 preclinical and clinical evidence (multiple authors
What Are the Considerations and Safety Notes
US$ 22.35
US$ 22.92
US$ 23.63
US$ 23.10
US$ 23.13
US$ 24.70
